How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

On February 5, 2026, OpenAI introduced GPT-5.3-Codex and wrote in its release notes that early versions of the model were “instrumental in creating itself,” helping to debug training runs, manage ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

There are problems in leetcode, most of code are C++ and Javascript, and I will keep updating every day, just for learning how to improve coding skill. And I will also collect some good articles about ...

Recent insider activity at Recursion Pharmaceuticals included 2 transactions totaling $97,222.74. One was a Tax Payment of $18,400.36 and the other was a Sale of $78,822.38. Average transaction ...